+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Ischemic Stroke Diagnosis Market - Growth, Trends, and Forecasts (2020-2025)

  • ID: 4771865
  • Report
  • July 2020
  • Region: Global
  • 122 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Cleveland Clinic
  • GE Healthcare
  • Hitachi Ltd
  • Koninklijke Philips NV
  • Mayo Clinic
  • Nihon Kohden Corporation
  • MORE
The rising prevalence of acute ischemic stroke cases is driving the global demand for both diagnostic and surgical procedures in acute stroke treatment. Technological advancements in surgical procedures, along with a rising ageing population, increased demand for minimally invasive procedures, and growth in health care spending is the other major factors driving the growth of the global acute ischemic stroke diagnosis and treatment market. Excessive usage of medication for the treatment of ischemic stroke and the high cost of surgical procedures are hindering the growth of the market.

Key Market Trends

The Computerized Tomography (CT) Segment Led the Global Market in 2018

Imaging studies are used in ischemic diagnosis for the detection of haemorrhage in the acute stroke patient, in order to assess the degree of brain injury and to identify the vascular lesion responsible for the ischemic deficit.

Some advanced CT and MRI technologies are able to distinguish between brain tissue that is irreversibly infarcted and that which is potentially salvageable, thereby allowing better selection of patients likely to benefit from therapy.

In 2018, the leading diagnostic segment was computed tomography. The highest share of CT techniques is attributable to widespread access and speed of acquisition. In the hyperacute phase, a non-contrast CT (NCCT) scan is usually ordered to exclude or confirm haemorrhage; it is highly sensitive for this indication.

North America Holds the Largest Market Share

By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle-East & Africa (MEA), and South America. North America is the largest market for acute ischemic stroke diagnosis devices and is estimated to continue its stronghold of the market, owing to favourable government initiatives, technological innovations, and increasing demand for ischemic stroke products.

Asia-Pacific is expected to be the fastest-growing market for acute ischemic stroke diagnosis, owing to the increasing incidences of ischemic stroke cases in the region. Manufacturers are expanding their operations in the Asia-Pacific region, as these regions hold immense potential for market growth.

Competitive Landscape

The leading vendors of acute ischemic stroke diagnosis products are expanding their operations in Asian countries (India, China, Japan, and South Korea), as these economies hold immense potential for acute ischemic stroke diagnosis and treatment products. Major players operating in the global acute ischemic stroke diagnosis and treatment market include Agilent Technologies, Johnson and Johnson, Bio-Rad Laboratories, and Abbott Laboratories.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Cleveland Clinic
  • GE Healthcare
  • Hitachi Ltd
  • Koninklijke Philips NV
  • Mayo Clinic
  • Nihon Kohden Corporation
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 The Rising Number of Acute Stroke Patients
4.2.2 Technological Innovations in Diagnostic and Surgical Devices
4.3 Market Restraints
4.3.1 Alternative Treatments and High Costs
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 Diagnostic Type
5.1.1 Computed Tomography
5.1.2 Magnetic Resonance Imaging
5.1.3 Carotid Ultrasound
5.1.4 Cerebral Angiography
5.1.5 Electrocardiography
5.1.6 Echocardiography
5.1.7 Other Diagnostic Types
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle East & Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle East & Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Fujifilm Holdings Corporation
6.1.2 Samsung Electronics Co. Ltd
6.1.3 GE Healthcare
6.1.4 Hitachi Ltd
6.1.5 Nihon Kohden Corporation
6.1.6 Canon Medical Systems Corporation
6.1.7 Koninklijke Philips NV
6.1.8 Siemens Healthineers AG
6.1.9 Mindray Medical International Limited
6.1.10 Nanavati Super Speciality Hospital
6.1.11 Mayo Clinic
6.1.12 Cleveland Clinic
6.1.13 Global Diagnostics (Integral Diagnostics Group)
6.1.14 Memorial Health System (Memorial Medical Center)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Fujifilm Holdings Corporation
  • Samsung Electronics Co. Ltd
  • GE Healthcare
  • Hitachi Ltd
  • Nihon Kohden Corporation
  • Canon Medical Systems Corporation
  • Koninklijke Philips NV
  • Siemens Healthineers AG
  • Mindray Medical International Limited
  • Nanavati Super Speciality Hospital
  • Mayo Clinic
  • Cleveland Clinic
  • Global Diagnostics (Integral Diagnostics Group)
  • Memorial Health System (Memorial Medical Center)
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll